fenofibric acid has been researched along with Cardiovascular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burns, KM; Carlson, DM; Kelly, MT; Lele, A; Setze, CM; Stolzenbach, JC; Weinstein, DL; Williams, LA | 1 |
| Hilleman, DE; Maciejewski, SR; Mohiuddin, SM; Schima, SM; Williams, MA | 1 |
| Elisaf, MS; Kei, A; Milionis, HJ; Moutzouri, E | 1 |
2 review(s) available for fenofibric acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acid.
Topics: Cardiovascular Diseases; Cholesterol, LDL; Delayed-Action Preparations; Drug Delivery Systems; Dyslipidemias; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents | 2010 |
Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combination; Dyslipidemias; Fenofibrate; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Practice Guidelines as Topic | 2010 |
1 trial(s) available for fenofibric acid and Cardiovascular Diseases
| Article | Year |
|---|---|
A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, LDL; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Dyslipidemias; Female; Fenofibrate; Fluorobenzenes; Humans; Hypolipidemic Agents; Male; Middle Aged; Pyrimidines; Renal Insufficiency, Chronic; Rosuvastatin Calcium; Sulfonamides; Triglycerides; Young Adult | 2013 |
1 other study(ies) available for fenofibric acid and Cardiovascular Diseases
| Article | Year |
|---|---|
Fenofibrates get a second look. Research shows popular drugs fail to lower cardiovascular risk for most patients already taking a statin.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Triglycerides | 2010 |